Published in Am J Nephrol on August 11, 2004
Thrombopoietin enhances expression of vascular endothelial growth factor (VEGF) in primitive hematopoietic cells through induction of HIF-1alpha. Blood (2005) 1.03
The effects of nonspecific HIF1α inhibitors on development of castrate resistance and metastases in prostate cancer. Cancer Med (2014) 0.91
The relationship between serum hypoxia-inducible factor 1α and coronary artery calcification in asymptomatic type 2 diabetic patients. Cardiovasc Diabetol (2014) 0.80
Neuroprotection after traumatic brain injury in heat-acclimated mice involves induced neurogenesis and activation of angiotensin receptor type 2 signaling. J Cereb Blood Flow Metab (2014) 0.78
Hypoxia-Inducible Factor-1α Mediates Increased Sympathoexcitation via Glutamatergic N-Methyl-d-Aspartate Receptors in the Paraventricular Nucleus of Rats With Chronic Heart Failure. Circ Heart Fail (2016) 0.75
Role of ATP-dependent K channels in the effects of erythropoietin in renal ischaemia injury. Indian J Med Res (2015) 0.75
Assessing the Relationship of Angiotensin II Type 1 Receptors with Erythropoietin in a Human Model of Endogenous Angiotensin II Type 1 Receptor Antagonism. Cardiorenal Med (2015) 0.75
An immunofluorescence test for phospholipase-A₂-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis. Nephrol Dial Transplant (2011) 4.19
The IL-23/Th17 axis contributes to renal injury in experimental glomerulonephritis. J Am Soc Nephrol (2009) 2.06
Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy. Kidney Int (2012) 2.06
Angiotensin II activates nuclear transcription factor-kappaB through AT1 and AT2 receptors. Kidney Int (2002) 2.01
p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency. Kidney Int (2005) 1.67
Immunoadsorbtion and rituximab therapy in a second living-related kidney transplant patient with recurrent focal segmental glomerulosclerosis. Transpl Int (2007) 1.58
Albumin up-regulates the type II transforming growth factor-beta receptor in cultured proximal tubular cells. Kidney Int (2004) 1.53
Angiotensin II infusion ameliorates the early phase of a mesangioproliferative glomerulonephritis. Kidney Int (2002) 1.47
Renal and neurological involvement in typical Shiga toxin-associated HUS. Nat Rev Nephrol (2012) 1.36
CCR6 recruits regulatory T cells and Th17 cells to the kidney in glomerulonephritis. J Am Soc Nephrol (2010) 1.34
CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis. J Immunol (2009) 1.29
Analysis and classification of B-cell infiltrates in lupus and ANCA-associated nephritis. Kidney Int (2008) 1.25
Compartment-specific expression and function of the chemokine IP-10/CXCL10 in a model of renal endothelial microvascular injury. J Am Soc Nephrol (2005) 1.19
Linked common polymorphisms in the gelatinase a promoter are associated with diminished transcriptional response to estrogen and genetic fitness. J Biol Chem (2003) 1.19
BCA-1/CXCL13 expression is associated with CXCR5-positive B-cell cluster formation in acute renal transplant rejection. Kidney Int (2005) 1.16
Chemokine receptor CXCR3 mediates T cell recruitment and tissue injury in nephrotoxic nephritis in mice. J Am Soc Nephrol (2007) 1.11
CXCR3 and CCR5 positive T-cell recruitment in acute human renal allograft rejection. Transplantation (2004) 1.11
CD2-associated protein and glomerular disease. Lancet (2003) 1.10
Angiotensin II-induced mononuclear leukocyte interactions with arteriolar and venular endothelium are mediated by the release of different CC chemokines. J Immunol (2006) 1.08
Chemokines play a critical role in the cross-regulation of Th1 and Th17 immune responses in murine crescentic glomerulonephritis. Kidney Int (2012) 1.08
Expression of the chemokines MCP-1/CCL2 and RANTES/CCL5 is differentially regulated by infiltrating inflammatory cells. Kidney Int (2002) 1.08
The chemokine receptor 5 Delta32 mutation is associated with increased renal survival in patients with IgA nephropathy. Kidney Int (2005) 1.07
Renal failure and hypertension in Alagille syndrome with a novel JAG1 mutation. J Nephrol (2005) 1.04
Kidney diseases and chemokines. Curr Drug Targets (2006) 1.02
CCR5 deficiency aggravates crescentic glomerulonephritis in mice. J Immunol (2008) 1.01
My doctor said I should drink a lot! Recommendations for fluid intake in patients with chronic kidney disease. Clin J Am Soc Nephrol (2006) 1.00
IL-17A production by renal γδ T cells promotes kidney injury in crescentic GN. J Am Soc Nephrol (2012) 0.99
Deficiency of the interleukin 17/23 axis accelerates renal injury in mice with deoxycorticosterone acetate+angiotensin ii-induced hypertension. Hypertension (2013) 0.97
Rho kinase inhibition attenuates LPS-induced renal failure in mice in part by attenuation of NF-kappaB p65 signaling. Am J Physiol Renal Physiol (2009) 0.95
Immature renal dendritic cells recruit regulatory CXCR6(+) invariant natural killer T cells to attenuate crescentic GN. J Am Soc Nephrol (2012) 0.95
Rituximab removes intrarenal B cell clusters in patients with renal vascular allograft rejection. Transplantation (2007) 0.95
Resolution of renal inflammation: a new role for NF-kappaB1 (p50) in inflammatory kidney diseases. Am J Physiol Renal Physiol (2009) 0.94
Function of the Th17/interleukin-17A immune response in murine lupus nephritis. Arthritis Rheumatol (2015) 0.93
The expression of podocyte-specific proteins in parietal epithelial cells is regulated by protein degradation. Kidney Int (2013) 0.92
Renal IL-17 expression in human ANCA-associated glomerulonephritis. Am J Physiol Renal Physiol (2012) 0.91
Prostaglandin EP2 and EP4 receptors modulate expression of the chemokine CCL2 (MCP-1) in response to LPS-induced renal glomerular inflammation. Biochem J (2009) 0.91
Ubiquitin C-terminal hydrolase-l1 activity induces polyubiquitin accumulation in podocytes and increases proteinuria in rat membranous nephropathy. Am J Pathol (2011) 0.89
MicroRNA-155 drives TH17 immune response and tissue injury in experimental crescentic GN. J Am Soc Nephrol (2013) 0.89
The novel WD-repeat protein Morg1 acts as a molecular scaffold for hypoxia-inducible factor prolyl hydroxylase 3 (PHD3). J Biol Chem (2006) 0.89
Differential activation of NF-kappa B, AP-1, and C/EBP in endotoxin-tolerant rats: mechanisms for in vivo regulation of glomerular RANTES/CCL5 expression. J Immunol (2003) 0.88
Leukocyte-derived MMP9 is crucial for the recruitment of proinflammatory macrophages in experimental glomerulonephritis. Kidney Int (2013) 0.87
Protective role for CCR5 in murine lupus nephritis. Am J Physiol Renal Physiol (2012) 0.86
Autoantibodies against thrombospondin type 1 domain-containing 7A induce membranous nephropathy. J Clin Invest (2016) 0.85
Angiotensin II-induced hypertrophy of proximal tubular cells requires p27Kip1. Kidney Int (2003) 0.85
The transcriptional regulation of podocin (NPHS2) by Lmx1b and a promoter single nucleotide polymorphism. Cell Mol Biol Lett (2009) 0.85
Clinical features of critically ill patients with Shiga toxin-induced hemolytic uremic syndrome. Crit Care Med (2013) 0.84
No association of the -2518 MCP-1 A/G promoter polymorphism with incidence and clinical course of IgA nephropathy. Nephrol Dial Transplant (2004) 0.83
Existence of a regulatory loop between MCP-1 and TGF-beta in glomerular immune injury. Am J Physiol Renal Physiol (2002) 0.83
Angiotensin II's antiproliferative effects mediated through AT2-receptors depend on down-regulation of SM-20. Lab Invest (2002) 0.82
Effects of different PPARgamma-agonists on MCP-1 expression and monocyte recruitment in experimental glomerulonephritis. Kidney Int (2002) 0.81
Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy. N Engl J Med (2015) 0.81
Beneficial and adverse renal and vascular effects of the vasopeptidase inhibitor omapatrilat in renovascular hypertensive rats. Nephrol Dial Transplant (2003) 0.81
Chemokines and B cells in renal inflammation and allograft rejection. Front Biosci (Schol Ed) (2009) 0.80
Induction of p27KIP1 after unilateral ureteral obstruction is independent of angiotensin II. Kidney Int (2002) 0.80
Gene therapy with an E2F transcription factor decoy inhibits cell cycle progression in rat anti-Thy 1 glomerulonephritis. Int J Mol Med (2004) 0.80
Lack of type VIII collagen in mice ameliorates diabetic nephropathy. Diabetes (2009) 0.80
Chronic anti-Thy-1 nephritis is aggravated in the nonclipped but not in the clipped kidney of Goldblatt hypertensive rats. Kidney Int (2002) 0.79
Characterization of the transcriptional regulation of the human MT1-MMP gene and association of risk reduction for focal-segmental glomerulosclerosis with two functional promoter SNPs. Nephrol Dial Transplant (2008) 0.78
B-cell-derived IL-10 does not vitally contribute to the clinical course of glomerulonephritis. Eur J Immunol (2013) 0.78
Formation of lymphoid-like tissue in the kidney--is there a role for chemokines? Nephrol Dial Transplant (2006) 0.78
Acute cellular allograft rejection in homozygous CCR5 Delta32 patients after renal transplantation. Transplantation (2007) 0.78
15-deoxy-Delta12,14-prostaglandin J2 inhibits INF-gamma-induced JAK/STAT1 signalling pathway activation and IP-10/CXCL10 expression in mesangial cells. Nephrol Dial Transplant (2008) 0.77
A new partnership between TGF-beta1 and glucocorticoids in the network of inflammation. Kidney Int (2003) 0.76
Inhibition of platelet-derived growth factor-induced mesangial cell proliferation by cyclooxygenase-2 overexpression is abolished through reactive oxygen species. FEBS Lett (2006) 0.76
Enhanced expression of selenocysteine lyase in acute glomerulonephritis and its regulation by AP-1. Cell Mol Biol Lett (2006) 0.76
Immediate versus long-term effect of rituximab in recurrent focal segmental glomerulosclerosis. Transpl Int (2008) 0.75
Remembrance of things past: tumoural calcifications in a haemodialysis patient. Nephrol Dial Transplant (2002) 0.75
No association between a genetic variant of the p22(phox) component of NAD(P)H oxidase and the incidence and progression of IgA nephropathy. Nephrol Dial Transplant (2002) 0.75
ISN Forefronts Symposium 2010 in Sylt, Germany: 'Induction and Resolution of Renal Inflammation'. Kidney Int (2011) 0.75
A 63-year-old man with acute abdominal pain and laboratory signs of rapid progressive renal disease. Nephrol Dial Transplant (2004) 0.75
A patient with autosomal dominant polycystic kidney and liver disease presenting with urinary tract infection...'Unable to see the wood for the trees'. Nephrol Dial Transplant (2006) 0.75
[An old lady with hyponatremia and recurrent falls]. Med Klin (Munich) (2010) 0.75
An expensive multifactorial renal failure. Nephrol Dial Transplant (2004) 0.75
A woman with increasing weakness of the legs and irregular heartbeat who took her husband's medication. Nephrol Dial Transplant (2002) 0.75